Status:
UNKNOWN
A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients
Lead Sponsor:
Aga Khan University
Collaborating Sponsors:
University of Karachi
Conditions:
Covid-19
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Pakistan is a resource restraint country, it's not possible to carry out coronavirus testing at mass scale. Simple cost effective intervention against the present pandemic is highly desirable. For pa...
Detailed Description
It will be a parallel group, quadruple blind-randomized controlled pilot trial annexed with a laboratory based study. Clinical trial will be carried out at the Aga Khan University Hospital (AKUH), Kar...
Eligibility Criteria
Inclusion
- The inclusion criteria are laboratory confirmed Covid-19 positive male or female subjects in the age range of 18-65 years, within seven days of the onset of mild to moderate symptoms of viral infection, already admitted in the hospital.
Exclusion
- Edentulous patients, patients with low Glasgow coma score, intubated, immune-compromised, history of radiotherapy or chemotherapy will be excluded. Patients with known pre-existing chronic mucosal lesions such as lichen planus will also be excluded.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04341688
Start Date
December 1 2021
End Date
July 31 2022
Last Update
July 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.